Subscription Required

Only paid subscribers* to Specialty Pharmacy News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Specialty Pharmacy News receive

  • 12 monthly issues packed with news and strategies on this increasingly vital sector in health business, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from Managing Editor Angela Maas.
View a sample and get more information
January 2017

Recent Stories

From Specialty Pharmacy News - While many stakeholders within the health care industry hailed President Barack Obama’s Dec. 13 signing of the 21st Century Cures Act (SPN 12/16, p. 11), one group that isn’t very happy is home infusion providers. That’s because the legislation changed the way that certain Medicare Part B infusion therapies are reimbursed — and some of these providers stand to take a big hit to their bottom lines. This, in turn, could impact patient access to care, according to the National Home Infusion Association (NHIA), which is pushing to get the Jan. 1, 2017, implementation date moved back a couple of years. Read more

From new advances in medications including cancer drugs and biosimilars to changing… Read more

In responding to a request by the U.S. Supreme Court, the Solicitor… Read more

Horizon Blue Cross Blue Shield of New Jersey is no stranger to… Read more

From the Editor

Welcome to your Specialty Pharmacy News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with your comments on the last issue of Specialty Pharmacy News, story ideas for future issues, or any other suggestions you have that can make the newsletter more useful for you.

January 12, 2017
FDA Finalizes Naming Guidance for Biologics, Biosimilars

In final guidance, FDA says all biologics, not only biosimilars, will have four-letter suffixes; agency still considering “appropriate suffix format” for interchangeable biosimilars

December 28, 2016
FDA Issues More Biosimilar Guidance

FDA issues guidance on clinical pharmacology data needed to show a product is biosimilar to its reference drug

December 2, 2016
CMS Releases 2015 National Health Expenditures Data

CMS reports that spending on prescription drugs rose 9.0% in 2015, down from 12.4% growth in 2014 but an increase from 2.3% in 2013

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?